Abstract
Objective:
Reactive oxygen species (ROS) are involved in the initial process of atherosclerosis, whereas it remains to be determined how atherogenic stimulus causes ROS-mediated proinflammatory reactions. Here, we focused on proline-rich tyrosine kinase (PYK2)-mediated ROS generation and examined how atherogenic stimulus causes early proinflammatory reactions.
Methods and results:
PYK2-deficient (knockout [KO]) (PYK2-KO) mice were crossbred with apolipoprotein E (ApoE)-deficient (PYK2-KO/ApoE-KO) mice. PYK2-KO/ApoE-KO mice and endothelial cells (EC) were used for the study. Aortic atherogenic lesions in PYK2-KO/ApoE-KO mice were markedly decreased (55% versus ApoE-KO) after 8 weeks of a Western diet. Aortic PYK2 was activated as early as 7 days after the Western diet, when inflammatory cells were not yet activated. Addition of the proatherogenic oxidized phospholipid lysophosphatidylcholine caused activation of endothelial PYK2. Lysophosphatidylcholine-activated PYK2 induced NADPH oxidase-mediated ROS generation and ROS-mediated synthesis of tumor necrosis factor-α (TNFα), vascular cell adhesion molecule-1 (VCAM-1), monocyte chemotactic protein-1 (MCP-1), and p21Cip1/Ets-1. Neutralizing anti-TNFα antibody or knockdown of p21Cip1/Ets-1 system blocked the induction of VCAM-1 and MCP-1. PYK2 deficiency abolished these ROS-mediated proinflammatory reactions. Further analysis revealed that PYK2/ROS-mediated p21Cip1/Ets-1 activation upregulated the transcription of the MCP-1 gene in collaboration with p300 transcription coactivator.
Conclusions:
PYK2 is a key tyrosine kinase activated by high cholesterol exposure, which causes ROS-mediated TNFα release and induces TNFα-dependent expression of proinflammatory molecules via the p21Cip1/Ets-1/p300 transcription system.
Publication types
-
Research Support, Non-U.S. Gov't
-
Retracted Publication
MeSH terms
-
Animals
-
Aortic Diseases / enzymology*
-
Aortic Diseases / genetics
-
Aortic Diseases / pathology
-
Aortic Diseases / prevention & control
-
Apolipoproteins E / deficiency
-
Apolipoproteins E / genetics
-
Atherosclerosis / enzymology*
-
Atherosclerosis / genetics
-
Atherosclerosis / pathology
-
Atherosclerosis / prevention & control
-
Bone Marrow Transplantation
-
Cells, Cultured
-
Chemokine CCL2 / metabolism
-
Cyclin-Dependent Kinase Inhibitor p21 / genetics
-
Cyclin-Dependent Kinase Inhibitor p21 / metabolism*
-
Disease Models, Animal
-
Endothelial Cells / enzymology*
-
Endothelial Cells / pathology
-
Focal Adhesion Kinase 2 / deficiency
-
Focal Adhesion Kinase 2 / genetics
-
Focal Adhesion Kinase 2 / metabolism*
-
Hypercholesterolemia / enzymology
-
Hypercholesterolemia / genetics
-
Inflammation Mediators / metabolism*
-
Lipoproteins, LDL / metabolism
-
Lysophosphatidylcholines / metabolism
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
NADPH Oxidases / metabolism
-
Proto-Oncogene Protein c-ets-1 / genetics
-
Proto-Oncogene Protein c-ets-1 / metabolism*
-
RNA Interference
-
Reactive Oxygen Species / metabolism*
-
Signal Transduction
-
Time Factors
-
Transcriptional Activation
-
Transfection
-
Tumor Necrosis Factor-alpha / metabolism*
-
Vascular Cell Adhesion Molecule-1 / metabolism
-
p300-CBP Transcription Factors / genetics
-
p300-CBP Transcription Factors / metabolism*
Substances
-
Apolipoproteins E
-
Ccl2 protein, mouse
-
Cdkn1a protein, mouse
-
Chemokine CCL2
-
Cyclin-Dependent Kinase Inhibitor p21
-
Ets1 protein, mouse
-
Inflammation Mediators
-
Lipoproteins, LDL
-
Lysophosphatidylcholines
-
Proto-Oncogene Protein c-ets-1
-
Reactive Oxygen Species
-
Tumor Necrosis Factor-alpha
-
Vascular Cell Adhesion Molecule-1
-
oxidized low density lipoprotein
-
NADPH Oxidases
-
p300-CBP Transcription Factors
-
Focal Adhesion Kinase 2
-
Ptk2b protein, mouse